Home > Qtrly Results > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
Quarterly Results Analysis [Sep2024]

JENBURKT PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Quarterly Results

Standalone Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Revenues ₹41 Cr ₹33 Cr ₹39 Cr ₹36 Cr ₹38 Cr ₹29 Cr ₹35 Cr ₹35 Cr
Expenses ₹30 Cr ₹23 Cr ₹29 Cr ₹28 Cr ₹29 Cr ₹22 Cr ₹28 Cr ₹28 Cr
Operating Income ₹11 Cr ₹9 Cr ₹10 Cr ₹7 Cr ₹9 Cr ₹7 Cr ₹7 Cr ₹7 Cr
Other Income ₹2 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹13 Cr ₹10 Cr ₹10 Cr ₹8 Cr ₹10 Cr ₹7 Cr ₹8 Cr ₹8 Cr
Profit After Tax ₹10 Cr ₹7 Cr ₹8 Cr ₹5 Cr ₹7 Cr ₹5 Cr ₹6 Cr ₹5 Cr
EPS ₹21.75 ₹16.80 ₹17.86 ₹12.24 ₹16.59 ₹12.17 ₹14.40 ₹11.90
Industry Peers & Returns1W1M1Y
JENBURKT PHARMACEUTICALS -3.6% 9% 85.7%
SUN PHARMACEUTICAL INDUSTRIES -1.5% -5.7% 52.5%
CIPLA -4.4% -4.7% 25.5%
DR REDDYS LABORATORIES -3.1% -5.2% 18.1%
ZYDUS LIFESCIENCES -4.5% -10.6% 58.1%
DIVIS LABORATORIES -2.2% -6.5% 68.5%
MANKIND PHARMA -4.4% -4.8% 45.7%
TORRENT PHARMACEUTICALS -1.8% -9.8% 53.9%
LUPIN -3.6% -6.9% 73%

JENBURKT PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

26.68 %

Y-o-Y

7.64 %

Quarters Revenues % Change
Sep2024 ₹41 Cr
26.68
Jun2024 ₹33 Cr
-16.24
Mar2024 ₹39 Cr
8.92
Dec2023 ₹36 Cr
-6.87
Sep2023 ₹38 Cr
31.24
Jun2023 ₹29 Cr
-17.11
Mar2023 ₹35 Cr
1.83
Dec2022 ₹35 Cr -

JENBURKT PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

23.01 %

Y-o-Y

25.51 %

Quarters Operating Profit % Change
Sep2024 ₹11 Cr
23.01
Jun2024 ₹9 Cr
-5.72
Mar2024 ₹10 Cr
36.96
Dec2023 ₹7 Cr
-20.98
Sep2023 ₹9 Cr
30.67
Jun2023 ₹7 Cr
-7.08
Mar2023 ₹7 Cr
7.42
Dec2022 ₹7 Cr -
Operating Margins
Q-o-Q

-2.91 %

Y-o-Y

16.57 %

Quarters Operating Margin% % Change
Sep2024 27.72%
-2.91
Jun2024 28.55%
12.53
Mar2024 25.37%
25.78
Dec2023 20.17%
-15.18
Sep2023 23.78%
-0.42
Jun2023 23.88%
12.11
Mar2023 21.3%
5.50
Dec2022 20.19% -

JENBURKT PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

29.49 %

Y-o-Y

31.14 %

Quarters Profit After Tax % Change
Sep2024 ₹10 Cr
29.49
Jun2024 ₹7 Cr
-5.94
Mar2024 ₹8 Cr
45.90
Dec2023 ₹5 Cr
-26.21
Sep2023 ₹7 Cr
36.38
Jun2023 ₹5 Cr
-15.50
Mar2023 ₹6 Cr
16.93
Dec2022 ₹5 Cr -
PAT Margins
Q-o-Q

2.24 %

Y-o-Y

21.86 %

Quarters PAT Margin(%) % Change
Sep2024 23.3 %
2.24
Jun2024 22.79 %
12.27
Mar2024 20.3 %
33.99
Dec2023 15.15 %
-20.76
Sep2023 19.12 %
3.91
Jun2023 18.4 %
1.94
Mar2023 18.05 %
14.82
Dec2022 15.72 % -

JENBURKT PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

29.46 %

Y-o-Y

31.10 %

Quarters EPS % Change
Sep2024 ₹21.75
29.46
Jun2024 ₹16.8
-5.94
Mar2024 ₹17.86
45.92
Dec2023 ₹12.24
-26.22
Sep2023 ₹16.59
36.32
Jun2023 ₹12.17
-15.49
Mar2023 ₹14.4
21.01
Dec2022 ₹11.9 -

You may also like the below Video Courses